Tag: anti-SEMA4D
January 17, 2019
Vaccinex Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503
Vaccinex (Nasdaq:VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and... December 12, 2018